Polycystic Ovary Syndrome, Subclinical Hypothyroidism, the Cut-Off Value of Thyroid Stimulating Hormone; Is There a Link? Findings of a Population-Based Study
Diagnostics · 15.01.2023 · 13 (2) · 316
DOI: 10.3390/diagnostics13020316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 15.01.2023. Verfasst von Ehsan Rojhani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran 1985717…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract (Originalsprache)
Despite solid evidence regarding the association of over-hypothyroidism with polycystic ovary syndrome (PCOS), the relationship between PCOS and subclinical hypothyroidism (SCH) is still a topic of debate. In the present population-based study, we aimed to assess if there is a difference between PCOS and the control group regarding the upper reference limit of thyroid stimulating hormone (TSH). We also aimed to identify the prevalence of SCH in women with PCOS compared to controls. This study was conducted on data collected in the Iranian PCOS prevalence study and the Khuzestan PCOS prevalence study. Participants that met our eligibility criteria were categorized into two groups: PCOS (n = 207) and control (n = 644). Quantile and logistic regression models were used to explore the effect of PCOS status on TSH cut-off values and SCH, respectively. The 95 percentiles of TSH were not significantly different in the PCOS group compared to control ones (6.12 and 6.56 microU/mL, respectively). There was no statistically significant association between PCOS status and SCH (OR adjusted: 1.40; 95%CI: 0.79, 2.50; p = 0.2). The prevalence of SCH and the upper reference limit of TSH were not significantly different in PCOS and controls. Investigation of SCH in women with PCOS might be questionable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran.
- Tehran Medical Branch, Islamic Azad University, Tehran 19395/1495, Iran.
- Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran.
ORCID-Profile: Ehsan Rojhani
Förderung
- Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Zitieren
APA
Rojhani, E., Rahmati, M., Firouzi, F., Saei Ghare Naz, M., Azizi, F., & Ramezani Tehrani, F. (2023). Polycystic Ovary Syndrome, Subclinical Hypothyroidism, the Cut-Off Value of Thyroid Stimulating Hormone; Is There a Link? Findings of a Population-Based Study. Diagnostics, 13(2), 316. https://doi.org/10.3390/diagnostics13020316
Vancouver
Rojhani E, Rahmati M, Firouzi F, Saei Ghare Naz M, Azizi F, Ramezani Tehrani F. Polycystic Ovary Syndrome, Subclinical Hypothyroidism, the Cut-Off Value of Thyroid Stimulating Hormone; Is There a Link? Findings of a Population-Based Study. Diagnostics. 2023;13(2):316. doi:10.3390/diagnostics13020316
BibTeX
@article{Rojhani2023,
author = {Rojhani, Ehsan and Rahmati, Maryam and Firouzi, Faegheh and Saei Ghare Naz, Marzieh and Azizi, Fereidoun and Ramezani Tehrani, Fahimeh},
title = {Polycystic Ovary Syndrome, Subclinical Hypothyroidism, the Cut-Off Value of Thyroid Stimulating Hormone; Is There a Link? Findings of a Population-Based Study},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {2},
pages = {316},
doi = {10.3390/diagnostics13020316}
}
EUVIMED